The role of serotonin receptors in migraine headaches

Neurochemical Journal

Volumn 5, Issue 2, 2011, Pages 92-99

  Sokolov, A Y ^a,b,c   Lyubashina, O A ^a   Panteleev, S S ^a,b  

^a PAVLOV INSTITUTE OF PHYSIOLOGY   (Russian Federation)

^b PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^c NONE   (Russian Federation)

Author keywords

5 HT receptors; cerebral vasculature; headache; migraine; serotonin; trigeminal nerve; triptans

Indexed keywords

EID: 79958251933     PISSN: 18197124     EISSN: 18197132     Source Type: Journal    
DOI: 10.1134/S1819712411020085     Document Type: Review

References (97)

1. Srikiatkhachorn, A., Tarasub, N., and Govitrapong, P., Headache, 2000, vol. 40, pp. 343-350.
2. Amelin, A. V., Ignatov, Yu. D., and Skoromets, A. A., Migren' - patogenez, klinika i lechenie (Migrainepathogenesis, clinic, and treatment), St. Petersburg: SPb med. izd-vo, 2001.
3. Schurks, M. and Diener, H. C., Eur. J. Neurol., 2008, vol. 15, pp. 1279-1285.
4. Goadsby, P. J., Chabrit, A. R., Andreou, A. P., and Akerman, S., Neuroscience, 2009, vol. 161, pp. 327-341.
5. Messlinger, K., Exp. Brain Res., 2009, vol. 196, no. 1, pp. 179-193.
6. Edvinsson, L. and Uddman, R., Brain Res., 2005, vol. 48, no. 3, pp. 438-456.
7. Lambert, G. A., Hoskin, K. L., and Zagami, A. S., Neuropharm., 2004, vol. 47, pp. 92-105.
8. Bannister, K., Bee, L., and Dickenson, A., Neurother., 2009, vol. 6, no. 4, pp. 703-712.
9. Eggers, A. E., Med. Hypot., 2001, vol. 56, no. 3, pp. 360-363.
10. Srikiatkhachorn, A., Curr. Pain Headache Rep., 2001, vol. 5, no. 6, pp. 537-544.
11. Hamel, E., Cephalalgia, 2007, vol. 27, no. 11, pp. 1293-1300.
12. Panconesi, A., J. Headache Pain, 2008, vol. 9, no. 5, pp. 267-276.
13. Sakai, Y., Dobson, C., Diksic, M., Aube, M., and Hamel, E., Neurology, 2008, vol. 70, no. 6, pp. 431-439.
14. Jelencsik, I. and Ertsey, C., Molecular Pathomechanisms and New Trends in Drug Research, Kéri, G. and Toth, I., Eds., NW: CRC Press, 2002, pp. 334-349.
15. Tepper, S. J., Rapoport, A. M., and Sheftell, F. D., Arch. Neurol., 2002, vol. 59, pp. 1084-1088.
16. Izzati-Zade, K. F., Neurosci. Beh. Phys., 2008, vol. 38, no. 5, pp. 501-505.
17. Martínez-García, E., García-Iglesias, B., and Terrón, J. A., Auton. Autacoid. Pharmacol, 2009, vol. 29, nos. 1-2, pp. 43-50.
18. Mitsikostas, D. D. and Sanchez del Rio, M., Brain Res. Rev., 2001, vol. 35, no. 1, pp. 20-35.
19. Villalon, C. M., Centurion, D., Valdivia, L. F., de Vries, P., and Saxena, P. R., Cur. Vasc. Pharmacol., 2003, vol. 1, pp. 71-84.
20. Johnson, K. W., Phebus, L. A., and Cohen, M. L., Prog. Drug Res., 1998, vol. 51, pp. 219-244.
21. Mitsikostas, D. D. and Moskowitz, M. A., Neurol. Network Comm., 1998, vol. 2, pp. 232-235.
22. Hoyer, D., Clarke, D. E., Fozard, J., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., and Humphrey, P. A., Pharmacol. Rev., 1994, vol. 46, pp. 157-204.
23. Donaldson, C., Boers, P. M., Hoskin, K. L., Zagami, A. S., and Lambert, G. A., Neuropharmacol., 2002, vol. 42, no. 3, pp. 374-385.
24. Nilsson, T., Longmore, J., Shaw, D., Olesen, I. J., and Edvinsson, L., Br. J. Pharm., 1999, vol. 128, pp. 1133-1140.
25. Cumberbatch, M. J., Hill, R. G., and Hargreaves, J. R., Eur. J. Pharmacol., 1998, vol. 362, pp. 43-46.
26. Goadsby, P. J., Akerman, S., and Storer, R. J., Ann. Neurol., 2001, vol. 50, pp. 804-807.
27. Burstein, R. and Jakubowski, M., Ann. Neurol., 2004, vol. 55, no. 1, pp. 27-36.
28. Maneesri, S., Akerman, S., Lasalandra, M. P., Classey, J. D., and Goadsby, P. J., Cephalalgia, 2004, vol. 24, p. 148.
29. Harriott, A. M. and Gold, M. S., Cephalalgia, 2008, vol. 28, no. 9, pp. 933-944.
30. Ennis, M. D., Ghazal, N. B., Hoffman, R. L., Smith, M. W., Schlachter, S. K., Lawson, C. F., Im, W. B., Pregenzer, J. F., Svensson, K. A., Lewis, R. A., Hall, E. D., Sutter, D. M., and Harris, L. T., J. Med. Chem., 1998, vol. 41, pp. 2180-2183.
31. Centurion, D., Sanchez-Lopez, A., De Vries, P., Saxena, P. R., and Villalon, C. M., Br. J. Pharmacol., 2001, vol. 132, pp. 991-998.
32. Bouchelet, I., Case, B., Olivier, A., and Hamel, E., Br. J. Pharmacol., 2000, vol. 129, pp. 501-550.
33. Gomez-Mancilla, B., Cutler, N. R., Leibowitz, M. T., Spierings, E. L., Klapper, J. A., Diamond, S., Goldstein, J., Smith, T., Couch, J. R., Fleishaker, J., Azie, N., and Blunt, D. E., Cephalalgia, 2001, vol. 21, pp. 727-732.
34. Storer, R. J. and Goadsby, P. J., Brain, 1997, vol. 120, pp. 2171-2177.
35. Boers, P. M., Donaldson, C., Zagami, A. S., and Lambert, G. A., Cephalalgia, 2004, vol. 24, no. 2, pp. 99-109.
36. Shepheard, S., Edvinsson, L., Cumberbatch, M., Williamson, D., Mason, G., Webb, J., Boyce, S., Hill, R., and Hargreaves, R., Cephalalgia, 1999, vol. 19, pp. 851-858.
37. Goldstein, D. J., Roon, K. I., and Offen, W. W., Cephalalgia, 1999, vol. 19, no. 4, p. 318.
38. Johnson, K. W., Schaus, J. M., Durkin, M. M., Audia, J. E., Kaldor, S. W., Flaugh, M. E., Adham, N., Zgombick, J. M., Cohen, M. L., Branchek, T. A., and Phebus, L. A., Neuroreport, 1997, vol. 8, pp. 2237-2240.
39. Xu, Y. C., Johnson, K. W., Phebus, L. A., Cohen, M., Nelson, D. L., Schenck, K., Walker, C. D., Fritz, J. E., Kaldor, S. W., LeTourneau, M. E., Murff, R. E., Zgombick, J. M., Calligaro, D. O., Audia, J. E., and Schaus, J. M., J. Med. Chem., 2001, vol. 44, no. 24, pp. 4031-4034.
40. Filla, S. A., Mathes, B. M., Johnson, K. W., Phebus, L. A., Cohen, M. L., Nelson, D. L., Zgombick, J. M., Erickson, J. A., Schenck, K. W., Wainscott, D. B., Branchek, T. A., and Schaus, J. M., J. Med. Chem., 2003, vol. 46, no. 14, pp. 3060-3071.
41. Cohen, M. L. and Schenck, K., J. Pharmacol. Exp. Ther., 1999, vol. 290, pp. 935-939.
42. Mitsikostas, D. D., Sanchez del Rio, M., Moskowitz, M. A., and Waeber, C., Eur. J. Pharmacol., 1999, vol. 369, pp. 271-277.
43. Ahn, S. K., Khalmuratova, R., Jeon, S. Y., Kim, J. P., Park, J. J., Hur, D. G., Kim, D. W., and Balaban, C. D., Neuroreport, 2009, vol. 20, no. 2, pp. 111-115.
44. Evrard, A., Laporte, A. M., Chastanet, M., Hen, R., Hamon, M., and Adrien, J., Eur. J. Neurosci., 1999, vol. 11, no. 11, pp. 3823-3831.
45. Esteban, S., Lladó, J., Sastre-Coll, A., and García-Sevilla, J. A., Naunyn Schmiedbergs Arch. Pharmacol., 1999, vol. 360, no. 2, pp. 135-143.
46. Kishimoto, K., Koyama, S., and Akaike, N., Neuropharmacol., 2001, vol. 41, no. 5, pp. 529-538.
47. Rickels, K., Mathew, S., Banov, M. D., Zimbroff, D. L., Oshana, S., Parsons, E. C., Donahue, S. R., Kauffman, M., Iyer, G. R., and Reinhard, J. F., J. Clin. Psyhopharm., 2008, vol. 28, no. 2, pp. 235-239.
48. Boers, P. M., Donaldson, C., Zagami, A. S., and Lambert, G. A., Neuropharm., 2000, vol. 39, no. 10, pp. 1833-1847.
49. Martin, R. S. and Martin, G. R., Cephalalgia, 2001, vol. 21, no. 1, pp. 46-52.
50. Johnson, K. W., Nelson, D. L., Dieckman, D. K., Wainscott, D. B., Lucaites, V. L., Audia, J. E., Owton, W. M., and Phebus, L. A., Cephalalgia, 2003, vol. 23, no. 2, pp. 117-123.
51. Bonhaus, D. W., Chang, L. K., Cao, Z., Wong, L., Pulido-Rios, T., Webber, A., Leung, E., Flippin, L. A., Eglen, R. M., and Martin, G. R., in Cluster Headache and Related Conditions, Olesen, J. and Goadsby, P. J., Eds., New York: Oxford Univ. Press, 1999, vol. 9, pp. 278-286.
52. Okamoto, K., Imbe, H., Morikawa, Y., Itoh, M., Sekimoto, M., Nemoto, K., and Senba, E., Pain, 2002, vol. 99, pp. 133-143.
53. Okamoto, K., Kimura, A., Donishi, T., Imbe, H., Nishie, Y., Matsushita, H., Tamai, Y., and Senba, E., Neuroscience, 2006, vol. 143, pp. 597-606.
54. Srikiatkhachorn, A., Suwattanasophon, C., Ruangpattanatawee, U., and Phansuwan-Pujito, P., Headache, 2002, vol. 42, no. 7, pp. 566-574.
55. Mehrotra, S., Gupta, S., Garrelds, I. M., Villalón, C. M., Saxena, P. R., Bogers, A. J., and Maassenvandenbrink, A., Naunyn Schmiedebergs Arch. Pharmacol., 2006, vol. 374, no. 3, pp. 163-175.
56. Okamoto, K., Imbe, H., Kimura, A., Donishi, T., Tamai, Y., and Senba, E., Neuroscience, 2007, vol. 147, pp. 1090-1102.
57. Obata, H., Saito, S., Sakurazawa, S., Sasaki, M., Usui, T., and Goto, F., Pain, 2004, vol. 108, pp. 163-169.
58. Khasabov, S. G., Lopez-Garcia, J. A., Asghar, A. U., and King, A. E., Br. J. Pharm., 1999, vol. 127, pp. 843-852.
59. Wolf, H., Scand. J. Rheumatol., Suppl. 2000, vol. 113, pp. 37-45.
60. Farber, L., Haus, U., Spath, M., and Drechsler, S., Scand. J. Reum., 2004, vol. 119, pp. 2-8.
61. Farber, L., Drechsler, S., Ladenburger, S., Gschaidmeier, H., and Fischer, W., Eur. J. Pharm., 2007, vol. 560, no. 1, pp. 1-8.
62. Lambert, G. A., Donaldson, C., Hoskin, K. L., Boers, P. M., and Zagami, A. S., Naunyn Schmiedebergs Arch. Pharmacol., 2004, vol. 369, no. 6, pp. 591-601.
63. Okamoto, K., Imbe, H., Tashiro, A., Kumabe, S., and Senba, E., Neurosci. Let., 2004, vol. 367, pp. 259-263.
64. Dogrul, A., Ossipov, M. H., and Porreca, F., Brain Res., 2009, vol. 1280, pp. 52-59.
65. Okamoto, K., Kimura, A., Donishi, T., Imbe, H., Senba, E., and Tamai, Y., Neurosci, 2005, vol. 135, no. 2, pp. 569-581.
66. Thomas, D. R. and Hagan, J. J., Curr. Drug Targets CNS Neurol Disord, 2004, vol. 3, no. 1, pp. 81-90.
67. Caminero-Rodriguez, A. B. and Pareja, J. A., Rev. Neurol., 2008, vol. 47, no. 6, pp. 314-320.
68. Gellynck, E., Laenen, K., Andressen, K. W., Lintermans, B., De Martelaere, K., Matthys, A., Levy, F. O., Haegeman, G., Vanhoenacker, P., and van Craenenbroeck, K., Gene, 2008, vol. 426, nos. 1-2, pp. 23-31.
69. Terrón, J. A., Eur. J. Pharmacol., 2002, vol. 439, nos. 1-3, pp. 1-11.
70. Terrón, J. A. and Martínez-García, E., Eur. J. Pharmacol., 2007, vol. 560, no. 1, pp. 56-60.
71. Terrón, J. A., Bouchelet, I., and Hamel, E., Neurosci. Let., 2001, vol. 302, no. 1, pp. 9-12.
72. Doly, S., Fischer, J., Brisorgueil, M. J., Verg, D., and Conrath, M., J. Comp. Neurol., 2005, vol. 90, no. 3, pp. 256-269.
73. Dogrul, A. and Seyrek, M., Br. J. Pharmacol., 2006, vol. 149, no. 5, pp. 498-505.
74. Yanarates, O., Dogrul, A., Yildirim, V., Sahin, A., Sizlan, A., Seyrek, M., Akgül, O., Kozak, O., Kurt, E., and Aypar, U., Anesthesiology, 2010, vol. 112, no. 3, pp. 696-710.
75. Brenchat, A., Romero, L., García, M., Pujol, M., Burgueño, J., Torrens, A., Hamon, M., Baeyens, J. M., Buschmann, H., Zamanillo, D., and Vela, J. M., Pain, 2009, vol. 141, no. 3, pp. 239-247.
76. Rocha-González, H. I., Meneses, A., Carlton, S. M., and Granados-Soto, V., Pain, 2005, vol. 117, nos. 1-2, pp. 182-192.
77. Mnie-Filali, O., Lambás-Señas, L., Zimmer, L., and Haddjeri, N., Drug News Perspect., 2007, vol. 20, no. 10, pp. 613-618.
78. Hedlund, P. B., Psychopharmacology (Berl.), 2009, vol. 206, no. 3, pp. 345-354.
79. Ahonen, K., Hamalainen, M. L., Rantala, H., and Hoppu, K., Neurology, 2004, vol. 62, no. 6, pp. 883-887.
80. Ashcroft, D. M. and Millson, D., Pharmacoepid. Drug Saf., 2004, vol. 13, no. 2, pp. 73-82.
81. Carpay, J., Schoenen, J., Ahmad, F., Kinrade, F., and Boswell, D., Clin. Ther., 2004, vol. 26, no. 2, pp. 214-223.
82. Goadsby, P. J., Handb. Exp. Pharmacol., 2007, vol. 177, pp. 129-143.
83. Lambert, G. A., CNS Drug Rev., 2005, vol. 11, no. 3, pp. 289-316.
84. Goadsby, P. J. and Hoskin, K. L., Ann. Neurol., 1998, vol. 43, pp. 711-718.
85. Shields, K. G. and Goadsby, P. J., Neurob. Dis., 2006, vol. 23, pp. 491-501.
86. Bartsch, T., Knight, Y. E., and Goadsby, P. J., Ann. Neurol., 2004, vol. 56, pp. 371-381.
87. Jeong, H. J., Chenu, D., Johnson, E., Connor, M., and Vaughan, C. W., Molec. Pain, 2008, vol. 4, pp. 54-64.
88. Goldstein, D. J., Roon, K. I., Offen, W. W., Ramadan, N. M., Phebus, L. A., Johnson, K. W., Schaus, J. M., and Ferrari, M. D., Lancet, 2001, vol. 358, pp. 1230-1234.
89. Reuter, U., Pilgrim, A. J., Diener, H. C., Farkkila, M., and Ferrari, M. D., Cephalalgia, 2009, vol. 29, p. 122.
90. Cipolla, G., Sacco, S., Crema, F., Moro, E., De Ponti, F., and Frigo, G., Pharm. Res., 2001, vol. 43, no. 3, pp. 205-210.
91. Hoskin, K. L., Lambert, G. A., Donaldson, C., and Zagami, A. S., Brain Res., 2004, vol. 998, no. 1, pp. 91-99.
92. Nikai, T., Basbaum, A. I., and Ahn, A. H., Pain, 2008, vol. 139, no. 3, pp. 533-540.
93. Vera-Portocarrero, L. P., Ossipov, M. H., King, T., and Porreca, F., Gastroenterol., 2008, vol. 135, no. 4, pp. 1369-1378.
94. Tumelevich, B. Ch., Mechanisms of Action and Clinical Effectivity of Serotoninergic Drug Tropoxin in Migraine, Cand. Sci. (Med.) Dissertation, St. Petersburg: SPb-GMU im. akad. I. P. Pavlova, 2002, 124 p.
95. Krymchantowski, A. V., Silva, M. T., Barbosa, J. S., and Alves, L. A., Headache, 2004, vol. 42, no. 6, pp. 510-514.
96. Lewis, D. W., Diamond, S., Scott, D., and Jones, V., Headache, 2004, vol. 44, no. 3, pp. 230-237.
97. Ayata, C., Jin, H., Kudo, C., Dalkara, T., and Moskowitz, M. A., Ann. Neurol., 2006, vol. 59, no. 4, pp. 652-661.